BC Innovations | Dec 13, 2016
Distillery Therapeutics

Hepatic

INDICATION: Liver disease Mouse studies suggest inhibiting ABL1 or its downstream effector MLL4 could help treat hepatic steatosis. In a mouse model of diet-induced hepatic steatosis, liver levels of ABL1 were higher than in normal...
Items per page:
1 - 1 of 1